-
Je něco špatně v tomto záznamu ?
Is breastfeeding in MS harmful or not? An answer from real-world Czech data
P. Hradilek, O. Zapletalova, P. Hanulikova, EK. Havrdova, I. Woznicova, A. Mazouchova, J. Drahota, M. Lauer, I. Stetkarova, M. Valis, J. Libertinova, P. Stourac, J. Adamkova, R. Ampapa, M. Vachova, M. Dufek, A. Martinková, M. Peterka, E....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- kojení MeSH
- lidé MeSH
- progrese nemoci MeSH
- recidiva MeSH
- relabující-remitující roztroušená skleróza * farmakoterapie MeSH
- roztroušená skleróza * farmakoterapie epidemiologie MeSH
- těhotenství MeSH
- Check Tag
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
INTRODUCTION: The influence of breastfeeding and it ́s duration on the course of multiple sclerosis (MS) is unclear. Here we analyzed a real-world data for breastfeeding women with MS and their disease course collected from a Czech national registry ReMuS. OBJECTIVES: To identify risk factors associated with not initiating breastfeeding after delivery, to analyze the impact of breastfeeding on the MS disease course, evaluate the assumption, that breastfeeding is not harmful in MS patients, and compare the disease course by breastfeeding status. MATERIALS AND METHODS: Using propensity score matching we compared Expanded Disability Status Scale (EDSS), confirmed disease worsening (CDW) and annual relapse rate (ARR) in breastfeeding and non-breastfeeding MS patients according to disease duration, disease modifying treatment (DMT) before pregnancy, last EDSS score before conception, age, and ARR during pregnancy. We also compared these parameters between breastfeeding patients not using a DMT and non-breastfeeding patients who resumed DMT within 3 months after delivery. EDSS, ARR, and CDW were collected at 12, 24, and 36 months after delivery. RESULTS: A total of 1681 pregnancies that ended in delivery were analyzed from 2013 through 2020. Change in ARR and EDSS values and 6-months CDW did not significantly differ between the analyzed groups. Compared with non-breastfeeding women who resumed DMT early after delivery, breastfeeding women with MS did not experience worse clinical outcomes even without initiating a DMT. DISCUSSION: Breastfeeding in Czech women with MS did not negatively affect the disease course and can be supported. Patients with MS can be treated with certain DMTs alongside breastfeeding and there is no need to stop breastfeeding, if the patient is clinically stable.
1st Department of Neurology University Hospital U Svate Anny Brno Czech Republic
Department of Economic Statistics Prague University of Economics and Business Prague Czech Republic
Department of Neurology Faculty of Medicine and University Hospital in Pilsen Charles University
Department of Neurology Hospital Ceske Budejovice Czech Republic
Department of Neurology Hospital of Jihlava Czech Republic
Department of Neurology Hospital Pardubice Czech Republic
Department of Neurology KZ a s Hospital Teplice Czech Republic
Department of Neurology Tomas Bata Hospital Zlin Czech Republic
Department of Neurology University Hospital and Masaryk University Brno Czech Republic
Department of Neurology University Hospital Ostrava Czech Republic
Faculty of Medicine in Pilsen The Institute for the Care of Mother and Child Prague Czech Republic
Faculty of Medicine Ostrava University Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016691
- 003
- CZ-PrNML
- 005
- 20231026105625.0
- 007
- ta
- 008
- 231013s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.msard.2023.104790 $2 doi
- 035 __
- $a (PubMed)37348317
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Hradilek, Pavel $u Faculty of Medicine, Ostrava University, Czech Republic; Department of Neurology, University Hospital Ostrava, Czech Republic. Electronic address: pavel.hradilek@seznam.cz
- 245 10
- $a Is breastfeeding in MS harmful or not? An answer from real-world Czech data / $c P. Hradilek, O. Zapletalova, P. Hanulikova, EK. Havrdova, I. Woznicova, A. Mazouchova, J. Drahota, M. Lauer, I. Stetkarova, M. Valis, J. Libertinova, P. Stourac, J. Adamkova, R. Ampapa, M. Vachova, M. Dufek, A. Martinková, M. Peterka, E. Recmanova, J. Mares, D. Horakova
- 520 9_
- $a INTRODUCTION: The influence of breastfeeding and it ́s duration on the course of multiple sclerosis (MS) is unclear. Here we analyzed a real-world data for breastfeeding women with MS and their disease course collected from a Czech national registry ReMuS. OBJECTIVES: To identify risk factors associated with not initiating breastfeeding after delivery, to analyze the impact of breastfeeding on the MS disease course, evaluate the assumption, that breastfeeding is not harmful in MS patients, and compare the disease course by breastfeeding status. MATERIALS AND METHODS: Using propensity score matching we compared Expanded Disability Status Scale (EDSS), confirmed disease worsening (CDW) and annual relapse rate (ARR) in breastfeeding and non-breastfeeding MS patients according to disease duration, disease modifying treatment (DMT) before pregnancy, last EDSS score before conception, age, and ARR during pregnancy. We also compared these parameters between breastfeeding patients not using a DMT and non-breastfeeding patients who resumed DMT within 3 months after delivery. EDSS, ARR, and CDW were collected at 12, 24, and 36 months after delivery. RESULTS: A total of 1681 pregnancies that ended in delivery were analyzed from 2013 through 2020. Change in ARR and EDSS values and 6-months CDW did not significantly differ between the analyzed groups. Compared with non-breastfeeding women who resumed DMT early after delivery, breastfeeding women with MS did not experience worse clinical outcomes even without initiating a DMT. DISCUSSION: Breastfeeding in Czech women with MS did not negatively affect the disease course and can be supported. Patients with MS can be treated with certain DMTs alongside breastfeeding and there is no need to stop breastfeeding, if the patient is clinically stable.
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a roztroušená skleróza $x farmakoterapie $x epidemiologie $7 D009103
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a kojení $7 D001942
- 650 12
- $a relabující-remitující roztroušená skleróza $x farmakoterapie $7 D020529
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zapletalova, Olga $u Faculty of Medicine, Ostrava University, Czech Republic; Department of Neurology, University Hospital Ostrava, Czech Republic
- 700 1_
- $a Hanulikova, Petra $u Faculty of Medicine in Pilsen, The Institute for the Care of Mother and Child, Prague, Czech Republic
- 700 1_
- $a Havrdova, Eva Kubala $u Department of Neurology, and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Woznicova, Ivana $u Department of Neurology, University Hospital Ostrava, Czech Republic
- 700 1_
- $a Mazouchova, Aneta $u IMPULS Endowment Fund, ReMuS Registry, Czech Republic; Department of Economic Statistics, Prague University of Economics and Business, Prague, Czech Republic
- 700 1_
- $a Drahota, Jiri $u Department of Neurology, and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic; IMPULS Endowment Fund, ReMuS Registry, Czech Republic
- 700 1_
- $a Lauer, Michal $u IMPULS Endowment Fund, ReMuS Registry, Czech Republic; Prague University of Economics and Business, Czech Republic
- 700 1_
- $a Stetkarova, Ivana $u Department of Neurology, 3rd Faculty of Medicine, Charles University in Prague and Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Valis, Martin $u Department of Neurology, Faculty of Medicine and University Hospital Hradec Kralove, Charles University in Prague, Czech Republic
- 700 1_
- $a Libertinova, Jana $u Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Stourac, Pavel $u Department of Neurology, University Hospital and Masaryk University Brno, Czech Republic
- 700 1_
- $a Adamkova, Jana $u Department of Neurology, Hospital Ceske Budejovice, Czech Republic
- 700 1_
- $a Ampapa, Radek $u Department of Neurology, Hospital of Jihlava, Czech Republic
- 700 1_
- $a Vachova, Marta $u Department of Neurology, and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic; Department of Neurology, KZ a.s., Hospital Teplice, Czech Republic
- 700 1_
- $a Dufek, Michal $u 1st Department of Neurology, University Hospital U Svate Anny, Brno, Czech Republic
- 700 1_
- $a Martinková, Alena $u Department of Neurology, Hospital Pardubice, Czech Republic
- 700 1_
- $a Peterka, Marek $u Department of Neurology, Faculty of Medicine and University Hospital in Pilsen, Charles University
- 700 1_
- $a Recmanova, Eva $u Department of Neurology, Tomas Bata Hospital, Zlin, Czech Republic
- 700 1_
- $a Mares, Jan $u Department of Neurology, Faculty of Medicine, Palacky University and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Horakova, Dana $u Department of Neurology, and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00188780 $t Multiple sclerosis and related disorders $x 2211-0356 $g Roč. 76, č. - (2023), s. 104790
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37348317 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105620 $b ABA008
- 999 __
- $a ok $b bmc $g 2000294 $s 1203053
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 76 $c - $d 104790 $e 20230616 $i 2211-0356 $m Multiple sclerosis and related disorders $n Mult Scler Relat Disord $x MED00188780
- LZP __
- $a Pubmed-20231013
